Epicepts newspipe in May
1. EMEA update
2. Milestone payments Azixa
3. BP Phase III studie (Endo $90 milj milestinepayments)
4. NP-1 studie, $1 billion/year sale, not licensed, fully
owned by Epicept
Was said in the webcast I guess.
MYGN yesterday webcast link:
Looks like some nice buys coming through again, I would not be surprised if we went green, the wise investors are accumulating here before all the news. They do not want to pay $6.00 to $10.00 a share soon. Today was the lowest volume day I have seen, we would be green if we did not have those small sells earlier.